Koers Univo Pharmaceuticals Ltd TEL AVIV STOCK EXCHANGE
Aandelen
UNVO
IL0010935588
Biotechnologie & Medisch Onderzoek
Omzet 2019 | 0,82 3,1 0,77 | Omzet 2020 | 33,68 126,6 31,62 | Marktkapitalisatie | 75,1 mln. 282 mln. 70,5 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2019 | -11 mln. -41,35 mln. -10,33 mln. | Nettowinst (verlies) 2020 | - 0 0 | EV/omzet 2019 | 35.543.010 x |
Nettoliquiditeiten 2019 | 22,82 mln. 85,78 mln. 21,42 mln. | Nettoschuld 2020 | 4,12 mln. 15,49 mln. 3,87 mln. | EV/omzet 2020 | 2.352.105 x |
K/w-verhouding 2019 * |
-
| K/w-verhouding 2020 |
-
| Werknemers | - |
Dividendrendement 2019 * |
-
| Dividendrendement 2020 |
-
| Vrij verhandelbaar | 59,28% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Golan Bitton
CEO | Chief Executive Officer | 47 | 04-04-93 |
Jonathan Eilat
IRC | Investor Relations Contact | - | - |
Noam Frakash
AUD | Comptroller/Controller/Auditor | 41 | 01-01-22 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chaim Hurvitz
CHM | Chairman | 63 | 15-07-19 |
Golan Bitton
CEO | Chief Executive Officer | 47 | 04-04-93 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
-1,42% | 41,35 mld. | |
+42,15% | 40,38 mld. | |
+1,97% | 39,05 mld. | |
-14,19% | 26,67 mld. | |
+1,82% | 24,07 mld. | |
-24,55% | 18,36 mld. | |
-4,07% | 11,68 mld. | |
+21,36% | 11,6 mld. | |
+8,20% | 11,15 mld. |